Literature DB >> 26100007

Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome.

Shin Fukudo1, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Mamoru Watanabe, Kentaro Sugano, Tooru Shimosegawa.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26100007     DOI： 10.1007/s00535-015-1074-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods.

Authors:  Amir Qaseem; Vincenza Snow; Douglas K Owens; Paul Shekelle
Journal:  Ann Intern Med       Date:  2010-08-03       Impact factor: 25.391

2.  Description of Kampo medicines in the clinical practice guidelines for irritable bowel syndrome.

Authors:  Yoshiharu Motoo
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

3.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.